Tuesday Plenary

AbbvieLillyRelay Medical
AUTM Annual Meeting

Plenary: VCs Talk Back – The State of Early-Stage Science-Based Venture Capital 

Sponsored by  
Tuesday, February 12
9:00 a.m. – 10:30 a.m.
View Session Video Recording
Senior leadership from prominent VC firms (Jim Flynn, Deerfield Management; Jenna Foger, Alexandria Real Estate Equities; Yoav Tzruya, Jerusalem Venture Partners; and Carmichael Roberts, Breakthrough Energy Ventures and Material Impact) will join moderator Orin Herskowitz, from Columbia Tech Ventures, to discuss the complex intersection of venture capital and university tech transfer. This interactive, audience-driven session will cover topics such as current investment hypotheses; observed best practices from tech transfer offices; the dynamic between scientific founders and CEOs; how to break into a career in venture; working with strategic industry investors; how VCs think about geography and regional economic development; “double bottom line” funds with a social mission; the role IP plays in company funding decisions; IP strategies for start-ups; and emerging experiments for forging deeper ties between VCs and universities. 

Jim Flynn, Managing Partner, Deerfield Management, a ~$9B investment firm with ~$1.5B allocated for life science venture capital, including deep partnerships with Rockefeller / Cornell / MSKCC (via Bridge Medicine); Johns Hopkins; Vanderbilt; the Broad.    

Jenna Foger, SVP of Science & Technology, Alexandria Real Estate Equities/Alexandria Venture Investments, leads Alexandria’s NYC-based venture investment activities and other strategic projects to catalyze the local life science ecosystem, most recently spearheading the creation of Alexandria LaunchLabs and the Alexandria Seed Capital Platform. She has led over 20 early-stage investments in university-based startups (~4 from Columbia alone) and supports Alexandria’s initiatives in other core life science hubs across the country, each in close proximity to premier institutions including UCSF, Stanford, Harvard, MIT, UNC, CalTech, and UCSD. 

 Carmichael Roberts is Co-Founder and Managing Partner of Material Impact, a fund that seeks out transformative materials technologies and builds them into valuable products and enduring companies that solve real-world problems. He is also part of the leadership team at Breakthrough Energy Ventures, the $1B+ mission-oriented energy fund backed by Bill Gates, Jack Ma, Jeff Bezos, Michael Bloomberg, and others that is creating companies to address the threat of climate change and long-term sustainability of the planet. 

Yoav Tzruya, General Partner, Jerusalem Venture Partners, Israel’s longest standing and most successful VC fund, with over $1.3B in assets, having invest in more than 130 companies, with 34 notable exits, including 12 NASDAQ IPOs. Repetitively ranked as one of the top-10, global consistently performing funds. Generally focusing on big data, AI, cybersecurity, fintech, enterprise software, cloud, storage, media, semiconductor and communications; frequent investor in university startups; with deep partnerships at multiple universities (Ben Gurion, Tel-Aviv, Hebrew U, Technion, now in NYC with Columbia / NYU / Cornell Tech / CUNY around cybersecurity).
Orin Herskowitz is the Senior VP of Intellectual Property and Tech Transfer for Columbia University, as well as Executive Director of Columbia Technology Ventures (CTV). He is an Adjunct Professor at Columbia teaching IP for Entrepreneurs and has been peer reviewer for NSF and APLU grants. He serves on the Boards of the Center for American Entrepreneurship; the IBM Columbia Blockchain Center; the NYC Media Lab; the NYC AR VR Lab; and other organizations. He is a principal investigator for multiple innovation and entrepreneurship grants, such as PowerBridgeNY and CyberNYC and a former member of the National Advisory Committee on Innovation and Entrepreneurship (NACIE) for the Secretary of Commerce.

Annual Meeting Sponsors

Elanco Animal Health
Osage University Partners
Relay Medical Corp
Burford Capital
Boehringer Ingelheim Pharmaceuticals Inc.
Parker Highlander PLLC
Pfizer Inc
Marshall, Gerstein & Borun LLP
Michael Best & Friedrich LLP
MTI Biotech
Bereskin & Parr LLP
Schwegman Lundberg & Woessner
Hamilton Brook Smith Reynolds
Eli Lilly and Company
University of Toledo
Oblon, McClelland, Maier & Neustadt LLP
Blank Rome LLP
Aird & McBurney LP
Fish & Richardson PC
Polsinelli PC
Schwabe, Williamson & Wyatt PC
Baker, Donelson, Bearman, Caldwell & Berkowitz
Pabst Patent Group LLP
CrossPond Law
Smith, Gambrell & Russell
Hodgson Russ LLP
Quarles & Brady LLP
Licensing Executives Society
Royalty Pharma
Husch Blackwell